CoChat
Sign Up
Cited by 1,512T-cell and B-cell ImmunologyPsoriasis: Treatment and PathogenesisIL-33, ST2, and ILC Pathways

The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.

Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells

Open access
Seddiki, Nabila, Santner-Nanan, Brigitte, Martinson, Jeff, Zaunders, John, Sasson, Sarah, Landay, Alan, Solomon, Michael, Selby, Warwick, Alexander, Stephen I., Nanan, Ralph, Kelleher, Anthony, de St. Groth, Barbara Fazekas·2006·The Journal of Experimental Medicine
DOI 10.1084/jem.20060468PMC PMC2118333
Open this paper in CoChat — free accountOpen PDF

Abstract

Abnormalities in CD4+CD25+Foxp3+ regulatory T (T reg) cells have been implicated in susceptibility to allergic, autoimmune, and immunoinflammatory conditions. However, phenotypic and functional assessment of human T reg cells has been hampered by difficulty in distinguishing between CD25-expressing activated and regulatory T cells. Here, we show that expression of CD127, the α chain of the interleukin-7 receptor, allows an unambiguous flow cytometry–based distinction to be made between CD127lo T reg cells and CD127hi conventional T cells within the CD25+CD45RO+RA− effector/memory and CD45RA+RO− naive compartments in peripheral blood and lymph node. In healthy volunteers, peripheral blood CD25+CD127lo cells comprised 6.35 ± 0.26% of CD4+ T cells, of which 2.05 ± 0.14% expressed the naive subset marker CD45RA. Expression of FoxP3 protein and the CD127lo phenotype were highly correlated within the CD4+CD25+ population. Moreover, both effector/memory and naive CD25+CD127lo cells manifested suppressive activity in vitro, whereas CD25+CD127hi cells did not. Cell surface expression of CD127 therefore allows accurate estimation of T reg cell numbers and isolation of pure populations for in vitro studies and should contribute to our understanding of regulatory abnormalities in immunopathic diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1084/jem.20060468

Cites

30 of 30 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1. Expression of CD127 and FoxP3 in adult blood, lymph node, cord blood, and thymus. (a) Plots are gated for CD4+CD8− T cells. CD25+CD127lo cells are boxed and the percentage of cells in the box is shown. In the lymph node sample, CD25−CD127lo cells are also boxed. (b) Plots are gated for CD4+CD8− T cells. FoxP3+CD127lo cells are boxed and the percentage of cells in the box is shown. (c) Correlation between FoxP3+CD25+ and CD25+CD127lo phenotypes in peripheral blood. Gating of CD4+ cells for each subset is shown, followed by the distribution of gated cells according to the reciprocal subset. (d) Correlation between FoxP3+ and CD25+CD127lo phenotypes in thymus.
Figure 1. Expression of CD127 and FoxP3 in adult blood, lymph node, cord blood, and thymus. (a) Plots are gated for CD4+CD8− T cells. CD25+CD127lo cells are boxed and the percentage of cells in the box is shown. In the lymph node sample, CD25−CD127lo cells are also boxed. (b) Plots are gated for CD4+CD8− T cells. FoxP3+CD127lo cells are boxed and the percentage of cells in the box is shown. (c) Correlation between FoxP3+CD25+ and CD25+CD127lo phenotypes in peripheral blood. Gating of CD4+ cells for each subset is shown, followed by the distribution of gated cells according to the reciprocal subset. (d) Correlation between FoxP3+ and CD25+CD127lo phenotypes in thymus.CC BY-NC-SA · PubMed Central
Figure 2. Correlation between expression of FoxP3 and CD127lo phenotype. (a) Leukocytes from adult blood, lymph node, and cord blood were gated into CD3+CD4+CD45RA+ and CD45RA− populations. FoxP3+ cells are boxed and the percentage of cells in the box is shown, together with expression of CD25 versus CD127 within the FoxP3+ gate. (b) Correlation between the percentages of CD25+CD127lo and CD25+FoxP3+ cells within CD4+CD45RA+ and CD45RA− populations in nine peripheral blood samples from healthy volunteers.
Figure 2. Correlation between expression of FoxP3 and CD127lo phenotype. (a) Leukocytes from adult blood, lymph node, and cord blood were gated into CD3+CD4+CD45RA+ and CD45RA− populations. FoxP3+ cells are boxed and the percentage of cells in the box is shown, together with expression of CD25 versus CD127 within the FoxP3+ gate. (b) Correlation between the percentages of CD25+CD127lo and CD25+FoxP3+ cells within CD4+CD45RA+ and CD45RA− populations in nine peripheral blood samples from healthy volunteers.CC BY-NC-SA · PubMed Central
Figure 3. Percentages of CD4+CD25+CD127lo cells in peripheral blood from 43 healthy volunteers. (a) Gating strategy for CD4+ cells subdivided into CD45RA− and CD45RA+ subpopulations. Boxes indicate the placement of the analysis gates for each cell population. (b) CD45RA− and CD45RA+CD25+CD127lo cells, expressed as a percentage of total CD4+ T cells. Total T reg cell percentages were derived by adding together the values for CD45RA− and CD45RA+ T reg cell subsets. Horizontal bars represent the group means. (c) Relationship between various CD4+ T cell subpopulations and age.
Figure 3. Percentages of CD4+CD25+CD127lo cells in peripheral blood from 43 healthy volunteers. (a) Gating strategy for CD4+ cells subdivided into CD45RA− and CD45RA+ subpopulations. Boxes indicate the placement of the analysis gates for each cell population. (b) CD45RA− and CD45RA+CD25+CD127lo cells, expressed as a percentage of total CD4+ T cells. Total T reg cell percentages were derived by adding together the values for CD45RA− and CD45RA+ T reg cell subsets. Horizontal bars represent the group means. (c) Relationship between various CD4+ T cell subpopulations and age.CC BY-NC-SA · PubMed Central
Figure 4. Quantitative analysis of Foxp3 mRNA expression in sorted populations of CD4+ T cells. (a) Sorting strategy for isolation of subsets of CD4+ T cells from adult and cord blood. Dot plots are gated for lymphocytes expressing CD4, together with CD45RA in the case of adult blood. Numbered boxes indicate the placement of the flow sorting gates for each cell population. (b) RT qPCR for Foxp3 was performed in duplicate using RNA prepared from sorted cell populations. Sorted CD45RA− cells from four donors were compared, whereas sufficient CD45RA+ cells were available from only two donors. (c) RT qPCR for T-bet and GATA3 using RNA prepared from sorted cell populations from two adult donors.
Figure 4. Quantitative analysis of Foxp3 mRNA expression in sorted populations of CD4+ T cells. (a) Sorting strategy for isolation of subsets of CD4+ T cells from adult and cord blood. Dot plots are gated for lymphocytes expressing CD4, together with CD45RA in the case of adult blood. Numbered boxes indicate the placement of the flow sorting gates for each cell population. (b) RT qPCR for Foxp3 was performed in duplicate using RNA prepared from sorted cell populations. Sorted CD45RA− cells from four donors were compared, whereas sufficient CD45RA+ cells were available from only two donors. (c) RT qPCR for T-bet and GATA3 using RNA prepared from sorted cell populations from two adult donors.CC BY-NC-SA · PubMed Central
Figure 5. Suppression of in vitro proliferation by T reg cells from adult and cord blood. (a) Sorting strategy for isolation of subsets of CD4+ T cells. Dot plots are gated for lymphocytes expressing CD4, together with CD45RA in the case of adult blood. Numbered boxes indicate the placement of the flow sorting gates for each cell population. (b) Suppression by flow sorted populations (nos. 1–5) from adult blood and populations (nos. 6–8) from cord blood. Responder cells were sorted autologous CD4+CD45RA+CD25− cells (population 5) for adult blood and autologous CD4+CD25− cells (population 8) for cord blood. Ratios of suppressor to responder cells are shown above the figure. Bars represent the mean ± SEM of three to four replicate cultures. Assays of adult blood are representative of two independent experiments and the cord blood data are derived from a single experiment. (c) Strategy for isolation of subsets of CD4+CD127lo T cells from adult blood, sorted on the basis of CD25 expression. (d) Suppression and cytokine production by flow sorted populations (nos. 9–14) from adult blood. Responder cells were sorted autologous CD4+CD45RA+CD25− cells (population 14). Limit of detection in the cytokine assays is indicated by the dotted line. nd, not detected. (f) Transwell cultures of flow sorted populations (nos. 9, 13–14, and nil) at a 1:1 ratio.
Figure 5. Suppression of in vitro proliferation by T reg cells from adult and cord blood. (a) Sorting strategy for isolation of subsets of CD4+ T cells. Dot plots are gated for lymphocytes expressing CD4, together with CD45RA in the case of adult blood. Numbered boxes indicate the placement of the flow sorting gates for each cell population. (b) Suppression by flow sorted populations (nos. 1–5) from adult blood and populations (nos. 6–8) from cord blood. Responder cells were sorted autologous CD4+CD45RA+CD25− cells (population 5) for adult blood and autologous CD4+CD25− cells (population 8) for cord blood. Ratios of suppressor to responder cells are shown above the figure. Bars represent the mean ± SEM of three to four replicate cultures. Assays of adult blood are representative of two independent experiments and the cord blood data are derived from a single experiment. (c) Strategy for isolation of subsets of CD4+CD127lo T cells from adult blood, sorted on the basis of CD25 expression. (d) Suppression and cytokine production by flow sorted populations (nos. 9–14) from adult blood. Responder cells were sorted autologous CD4+CD45RA+CD25− cells (population 14). Limit of detection in the cytokine assays is indicated by the dotted line. nd, not detected. (f) Transwell cultures of flow sorted populations (nos. 9, 13–14, and nil) at a 1:1 ratio.CC BY-NC-SA · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 30 references

Research works printed but not linked: 1

  1. 2005, Hum. Immunol., 66, 13

Cited by

Sorted by citations

Related

See all

Metadata

Authors
Seddiki, N., Santner-Nanan, B., Martinson, J., Zaunders, J., Sasson, S., Landay, A., Solomon, M., Selby, W., Alexander, S. I., Nanan, R., Kelleher, A., & de St. Groth, B. F.
Affiliations
  • The University of Sydney (AU)
  • 4Department of Paediatrics, University of Sydney, Western Clinical School, Penrith, NSW 2751, Australia
  • Rush University Medical Center (US)
  • St Vincent's Hospital Sydney (AU)
  • Royal Prince Alfred Hospital (AU)
  • Children's Hospital at Westmead (AU)
  • UNSW Sydney (AU)
  • 1Centenary Institute of Cancer Medicine and Cell Biology, Faculty of Medicine, University of Sydney, Newtown, NSW 2042, Australia
ORCID
Venue
The Journal of Experimental Medicine
Publisher
Rockefeller University Press
Published
2006-07-03
Volume
203
Issue
7
Pages
1693-1700
ISSN
  • 0022-1007 (ISSN-L)
  • 1540-9538
DOI
10.1084/jem.20060468
PMC
PMC2118333
OpenAlex
W2168628806
Cited by
1,512
References
30
Citations by year
2026: 18 · 2025: 25 · 2024: 32 · 2023: 32 · 2022: 44 · 2021: 49 · 2020: 58 · 2019: 75 · 2018: 51 · 2017: 64 · 2016: 74 · 2015: 63 · 2014: 87 · 2013: 92 · 2012: 116
FWCI
45.91
Type
journal article
Language
en
Open access
Locations
  • The Journal of Experimental Medicine (publishedVersion)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion, cc-by-nc-sa)
  • PubMed (publishedVersion)
  • UNSWorks (University of New South Wales, Sydney, Australia) (submittedVersion, cc-by-nc-nd)
Funders
  • Crohn's and Colitis Foundation of America
  • Crohn's and Colitis Foundation
  • Medical Research Council
  • National Health and Medical Research Council
  • National Institute of Allergy and Infectious Diseases (P01AI055793, AI55793, U19AI055793)
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
  • Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
Keywords
regulatory T cells, CD127, interleukin-2 receptor, Foxp3, CD25, CD4+ T cells, naive T cells, effector memory T cells
MeSH terms
Adult, Humans, Infant, Newborn, Lymphocyte Activation, Receptors, Interleukin-2, T-Lymphocyte Subsets, Receptors, Interleukin-7, T-Lymphocytes, Regulatory

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review